To perform a systematic review of studies describing paediatric adverse drug reactions (ADRs) conducted from national pharmacovigilance databases.
to explore the differences between ADRs and drugs responsible in different countries.
METHODS
A systematic literature search of published studies describing ADRs from national spontaneous reporting pharmacovigilance databases was performed. In order to capture the relevant articles, the following terms and/or keywords assigned to articles which studied ADRs from databases were used: adverse drug reaction*, adverse effect*, adverse event* side effect*, pharmacovigilance, spontaneous reporting, adverse drug reaction reporting system, adverse drug reaction reporting, drug surveillance program and adverse event reporting. The databases used were PubMed, Embase and MEDLINE. The PubMed database was searched from when the WHO Collaborating Centre for International Drug Monitoring in Uppsala was established in 1978 to March 2015. The WHO centre receives individual case safety reports of suspected ADRs from national pharmacovigilance centres around the world [7] .
Embase and MEDLINE were searched from 1980 to March 2015 and 1947 to March 2015 respectively. In addition to these searches, the reference lists of publications were also searched. The search strategy is as shown below in Table 1 .
Articles which described ADRs from national, international or regional pharmacovigilance databases were considered. Studies describing specific ADRs and drugs, vaccines, specific treatments and procedures for disease conditions in pharmacovigilance databases were excluded. All ADR studies outside of national, international or regional pharmacovigilance databases were also excluded.
All the included articles were considered by country of study, population, duration of study, number of patients/reports, notifiers, types of drugs and ADRs, death reports, and whether the data used for the studies were from a regional, national or international ADR database. The articles identified were separated into those reporting on the general population and paediatric population. Only the paediatric studies were analysed.
The ADR reporting rate for studies where this was not reported was calculated as follows:
[Reporting rate = annual average number of reports/population X 1 million]
The population estimates were taken from United Nations Population Division, World Population Prospects: The 2012 Revision [8] .
RESULTS
The literature search produced a total of 6720 articles from PubMed, Embase and MEDLINE. When the inclusion and exclusion criteria were applied, 41articles were identified, made up of 20 for paediatric studies and 21 for general population studies ( Figure 1 ). Only the 20 paediatric studies were analysed.
Summary of findings
The 20 studies reviewed included 3 international, 12 national and 5 regional studies.
The majority of the studies were conducted in Europe. Four were from North America, two from Latin America, one from Asia and none from Africa.
Eight of the studies excluded vaccines (including all four from North America) ( Table 2 ). The majority of the studies grouped ADRs in system organ class (SOC) and suspect drugs in anatomical therapeutic class (ATC) or drug class, and presented them in percentages of first, second and third most frequently reported. The type of notifiers and death reports were also presented in percentages.
The period of time data was collected for the studies ranged from 3 -37 years. The 37-year data described fatal suspected ADRs in UK between 1964 and 2000. For the studies which described seriousness of the events, the percentages of ADRs or reports ranged between 2 -68% of the total number of ADRs or reports. The highest proportion of serious reports was from North America (42 -62%). Four studies described reporting rates. The reporting rates for the other studies were calculated using an estimate of the childhood population for the year of study. The highest ADR reporting rates of 634 and 1458 reports per year per million children were described in regional studies conducted in Cuba in 2010 and 2012 respectively.
Nine studies described notifiers of ADRs (Table 3 ). Doctors were the largest group of reporters in eight of the studies. Pharmacists and other HCPs (including nurses) also submitted reports in most countries. The largest proportion of reports from consumers was from the USA.
Reported ADRs
The majority of the studies reported skin disorders (rash and urticaria) as the most frequent ADRs (Table 4 ). Other common ADRs were nervous system disorders (headache, dizziness and drowsiness), and pyrexia/fever. The less commonly reported ADRs were convulsions, diarrhoea and agitation. One study [19] described only fatal reports, and the most frequent fatal ADR in this study was hepatic failure.
The majority of the studies which ranked the frequency of ADRs described them in system organ class. Only a few studies described ADRs in lowest level terms.
Reported drugs
The most frequently reported drugs are shown in Table 5 . Antibiotics and vaccines were the most frequently reported drugs in almost all the studies identified in Europe, Latin America and Asia. Amoxicillin was the most frequently reported individual antibiotic (where this was stated) apart from in one Italian study where it was second after amoxicillin/clavulanic acid and in one Chinese study where cefuroxime was the most frequent.
In contrast, in North America, drugs used for treating attention deficit hyperactivity disorders (methylphenidate was named in one study) and isotretinoin were most frequently reported. There was no uniformity in the way frequency of drugs reported were described in the studies. In most studies, anatomic therapeutic class were used and in others, specific drugs were described.
Deaths reported
The studies conducted in North America reported the highest fatality rates, which ranged from 3.4 -13.0% (Table 6 ). These rates contrasted sharply with the rates reported in Europe, which ranged between 0.1 -2.2% with a mean rate of 0.8%. In the UK study [19] which described 37-year data, 0.8% fatality was recorded.
DISCUSSION
Systemic anti-infectives and vaccines were the group of drugs most frequently associated with ADRs in studies in Europe, Asia and Latin America. This reflects the widespread use of anti-infectives and vaccines in children [27, 28] . Many antiinfectives, however, are prescribed inappropriately [5, 6] . Reducing inappropriate prescribing would reduce the number of ADRs. In contrast, in North America Sweden [16] and USA [21, 24] . The high reporting rates recorded from the studies in a regional ADR database in Cuba [3, 25] was attributed to a special educational programme on pharmacovigilance for healthcare professionals. The high number of reports received per year in these countries is an indication of success of the reporting scheme.
Even though most of the studies in Europe and North America showed evidence of efficient reporting scheme, not all the HPCs were actively engaged in reporting ADRs. The results showed physicians and doctors submitted more reports than pharmacists and nurses. Other HPCs, especially nurses, could be encouraged by giving them focussed education to detect and report ADRs [30] , due to their unique role in observing patients' signs and symptoms. This approach has been successful in Sweden [31] and Latin America [25] .
This study has several limitations. Very few studies were conducted in Asia and Latin America, therefore, comparison of reported ADRs and drugs between the continents was not possible. No study was identified from Africa. Since the search was performed, however, we have published two studies describing ADR reports for children in Nigeria and Ghana [32, 33] . There was no uniformity in the reports in terms of ADRs and drugs description. Authors described ADRs and drugs differently in the studies. Some of the studies described ADRs in system organ class and others in lowest level reaction terms. The drugs were also described differently in anatomical therapeutic class and specific drugs/active substances. All these made comparison of the studies difficult.
CONCLUSIONS
The majority of the studies reviewed were from Europe and North America, no study was identified from Africa. ADR reporting rates are higher in Europe, North America and Latin America compared to Asia. Physicians and doctors reported more ADRs compared to pharmacists and nurses.
Vaccines and anti-infectives were most frequently associated with ADRs in children, with the exception of North America. The reported fatality rate was higher in North America.
Expert Opinion
ADRs are under-reported world-wide. The highest reporting rate was 1458 reports per year per million children in Cuba. Reporting rates in Europe (the continent with most studies) were considerably lower. Education about ADRs and their reporting is needed in Europe. Antibiotics and vaccines were the most frequently reported groups of drugs in most studies. They are also the most frequently prescribed groups of drugs to young children. Antibiotics are often prescribed inappropriately and efforts to improve rational prescribing are needed. In contrast in North America, drugs for ADHD were the most frequently reported drugs. This may be related to the widespread use of these drugs in North America. More reports of pharmacovigilance are needed from low and middle income countries in Africa, Asia and Latin America.
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